For details, see the “What should I know before using Pomalyst?” section. Multiple myeloma is a blood cancer that affects your bone marrow. It causes a buildup of cancer cells, which ...

One of the biggest risk is probably aging, myeloma is more common as people grow older. So the median age at which patients get diagnosed with myeloma is about 68/69 years. So it's still predominantly ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...

Protests against President Trump, Project 2025 and other issues have been planned in multiple cities for Wednesday. “We the people reject the agenda proposed by the Heritage Foundation in its ...

While there currently isn’t a cure for cancer, researchers are exploring several new treatments, including vaccines and gene editing, that could eventually change the face of cancer treatment.

Bristol-Myers Squibb (NYSE:BMY) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings per share (EPS) of $1.67, compared to the forecasted $1.47. The company ...

ATHENS, Ga., Feb. 06, 2025 (GLOBE NEWSWIRE) -- University Cancer & Blood Center (UCBC), a leading oncology and hematology practice for Northeast Georgia, is pleased to announce acclaimed breast ...